Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus VRM Vroom reports Q3 2025 earnings with no prior analyst consensus shares close unchanged today Is Stardust Power SDST stock worth evaluating for entry Q4 2025 EPS Beats Forecasts